We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$331B
AUM Growth
+$5.64B
Cap. Flow
-$2.7B
Cap. Flow %
-0.81%
Top 10 Hldgs %
12.38%
Holding
6,874
New
204
Increased
2,959
Reduced
3,018
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 9.92%
2 Financials 9.63%
3 Healthcare 8.27%
4 Consumer Discretionary 7.53%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQDE
5926
DELISTED
FlexShares International Quality Dividend Defensive Index Fund
IQDE
$19K ﹤0.01%
806
-46
-5% -$1.11K
BPTH
5927
DELISTED
Bio-Path Holdings Inc
BPTH
$19K ﹤0.01%
12
-17
-59% -$35.6K
DIVC
5928
DELISTED
C-Tracks Exchange Traded Notes Miller/Howard Strategic Dividend Reinvestor Due September 16, 2024
DIVC
$19K ﹤0.01%
599
-130
-18% -$4.02K
PTHN
5929
DELISTED
Patheon N.V.
PTHN
$19K ﹤0.01%
554
-16,417
-97% -$506K
ARGS
5930
DELISTED
Argos Therapeutics, Inc.
ARGS
$19K ﹤0.01%
2,660
+1,773
+200% +$15.1K
IRV
5931
DELISTED
SPDR S&P International Materials Sector
IRV
$19K ﹤0.01%
853
-31
-4% -$680
LBTYB
5932
DELISTED
Liberty Global plc Class B
LBTYB
$19K ﹤0.01%
585
-64
-10% -$2.07K
PALI icon
5933
Palisade Bio
PALI
$330M
0
TURN
5934
DELISTED
180 Degree Capital
TURN
$18K ﹤0.01%
3,670
CTEK
5935
DELISTED
CynergisTek, Inc.
CTEK
$18K ﹤0.01%
3,947
+1,080
+38% +$5.56K
CZFC
5936
DELISTED
Citizens First Corporation
CZFC
$18K ﹤0.01%
838
VCO
5937
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
$18K ﹤0.01%
585
+67
+13% +$2.16K
CGNT
5938
DELISTED
Cogentix Medical, Inc.
CGNT
$18K ﹤0.01%
10,778
+2,483
+30% +$4.26K
ZPIN
5939
DELISTED
Zhaopin Limited
ZPIN
$18K ﹤0.01%
978
-23,727
-96% -$429K
CKX icon
5940
CKX Lands
CKX
$17K ﹤0.01%
1,450
-1,450
-50% -$17.2K
CLWT icon
5941
Euro Tech Holdings
CLWT
$11M
$17K ﹤0.01%
19,875
+2,625
+15% +$2.29K
DCOY
5942
Decoy Therapeutics
DCOY
$2.19M
0
SNOA icon
5943
Sonoma Pharmaceuticals
SNOA
$5.26M
$17K ﹤0.01%
15
+4
+36% +$4.93K
VNCE icon
5944
Vince Holding Corp
VNCE
$81.3M
$17K ﹤0.01%
3,521
-814
-19% -$5.81K
WBIL icon
5945
WBI BullBear Quality 3000 ETF
WBIL
$30.1M
$17K ﹤0.01%
670
+16
+2% +$397
CXDC
5946
DELISTED
China XD Plastics Company Limited
CXDC
$17K ﹤0.01%
3,600
ANTH
5947
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$17K ﹤0.01%
10,834
-2,007
-16% -$4.5K
PFBX
5948
DELISTED
Peoples Financial Corp/MS
PFBX
$17K ﹤0.01%
1,268
+268
+27% +$3.69K
SNAK
5949
DELISTED
Inventure Foods, Inc.
SNAK
$17K ﹤0.01%
3,895
-22,682
-85% -$93K
UNXL
5950
DELISTED
Uni-Pixel, Inc.
UNXL
$17K ﹤0.01%
44,482
+1,892
+4% +$1K

Similar funds

Morgan Stanley's Q2 2017 Portfolio in Review

As of Q2 2017, Morgan Stanley held 6,874 positions worth $331B, up 1.7% from $325B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q2 2017 filing shows 204 new, 2,959 increased, 3,018 reduced and 165 closed positions. Its largest new stake was Altaba Inc: 6,949,032 shares worth $379M. The largest sale was iShares Russell 2000 ETF, an estimated $1.9B.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2017 buy was Altaba Inc: 6,949,032 shares worth $379M.
  • Morgan Stanley added most to Starbucks in Q2 2017, an estimated $500M increase.
  • Morgan Stanley's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.9B.
  • Morgan Stanley fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $539M.
  • Morgan Stanley's ten largest holdings make up 12% of its $331B portfolio in Q2 2017.
  • Morgan Stanley opened 204 new positions and closed 165 in Q2 2017.
  • Morgan Stanley's portfolio value rose 1.7% quarter-over-quarter to $331B.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.